These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17192366)

  • 1. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Service FJ; O'Brien PC
    Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Diabetes Reserach in Children Network (DirecNet) Study Group
    Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose variability, blood pressure and arterial stiffness in type 1 diabetes.
    Gordin D; Rönnback M; Forsblom C; Mäkinen V; Saraheimo M; Groop PH
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e4-7. PubMed ID: 18325620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of glycemic equilibrium on micro-angiopathic complications in insulin-dependent diabetes: results of recent studies].
    Zinman B
    Journ Annu Diabetol Hotel Dieu; 1994; ():93-100. PubMed ID: 8051834
    [No Abstract]   [Full Text] [Related]  

  • 7. Eating disorders and diabetic complications.
    Williams G; Gill GV
    N Engl J Med; 1997 Jun; 336(26):1905-6. PubMed ID: 9197220
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokines and type 1 diabetes complications: casual or causal association?
    Haller MJ; Schatz DA
    Pediatr Diabetes; 2008 Feb; 9(1):1-2. PubMed ID: 18211629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intensified treatment of diabetes prevents complications].
    Koivisto V
    Duodecim; 1993; 109(19):1622-4. PubMed ID: 7736979
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
    Stevanovic RD; Fisher ND; Lansang CM; Freeman KD; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):85-92. PubMed ID: 17703435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
    Chalew S; Hempe J; McCarter R
    Diabetes; 2008 Feb; 57(2):e4; author reply e5. PubMed ID: 18227521
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
    Hamed SA; Amine NF; Galal GM; Helal SR; Tag El-Din LM; Shawky OA; Ahmed EA; Abdel Rahman MS
    J Stroke Cerebrovasc Dis; 2008; 17(2):86-94. PubMed ID: 18346651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress is, convincingly, the mediator of the dangerous effects of glucose variability.
    Ceriello A; Ihnat M
    Diabet Med; 2010 Aug; 27(8):968. PubMed ID: 20653758
    [No Abstract]   [Full Text] [Related]  

  • 17. Cigarette smoking, smoking cessation, and diabetes.
    Tonstad S
    Diabetes Res Clin Pract; 2009 Jul; 85(1):4-13. PubMed ID: 19427049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in the young: what are their long term health prospects?
    Greene S
    Arch Dis Child; 2009 Apr; 94(4):251-3. PubMed ID: 19307199
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.
    Rosa JS; Flores RL; Oliver SR; Pontello AM; Zaldivar FP; Galassetti PR
    Pediatr Diabetes; 2008 Feb; 9(1):9-16. PubMed ID: 18211631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.
    De Caterina R; Madonna R; Bertolotto A; Schmidt EB
    Diabetes Care; 2007 Apr; 30(4):1012-26. PubMed ID: 17251279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.